Prescription and dispensing duration of medicines for hypertension and other chronic conditions: a review of international policies and evidence to inform the Australian setting

Author:

af Geijerstam PederORCID,Falster Michael O.ORCID,Chalmers JohnORCID,McLachlan Andrew J.ORCID,Rodgers AnthonyORCID,Schutte Aletta E.ORCID

Abstract

AbstractThe duration of treatment for which a physician may prescribe a medicine, ‘prescription duration’, is often dispensed at the pharmacy on multiple occasions of shorter time periods, ‘dispensing duration’. These durations vary significantly between and within countries. In Australia, the quantity of medication supplied at each dispensing has recently been extended from 30 to 60 days for a selection of medicines used for chronic health conditions, such as diabetes and hypertension. Dispensing durations vary between countries, with 30, 60 or 90 days being the most common—with 90 days aligning with the recommendation of the 2023 Global Report on Hypertension from the World Health Organization. The full impact of shorter vs longer prescription durations on health costs and outcomes is unknown, but current evidence suggests that 90-day dispensing could reduce costs and improve patient convenience and adherence. More rigorous research is needed.

Publisher

Springer Science and Business Media LLC

Reference73 articles.

1. The Australian Bureau of Statistics. Health conditions prevalence. https://www.abs.gov.au/statistics/health/health-conditions-and-risks/health-conditions-prevalence/2020-21. Accessed 30 Oct 2023.

2. The Australian Bureau of Statistics. Pharmaceutical benefits scheme supplied medications. https://www.abs.gov.au/articles/pharmaceutical-benefits-scheme-supplied-medications. Accessed 30 Oct 2023.

3. The Australian Institute of Health and Welfare. Medicines in the health system. https://www.aihw.gov.au/reports/medicines/medicines-in-the-health-system. Accessed 1 Nov 2023.

4. Atkins ER, Nguyen LH, Chatterton ML, Schutte AE, Rodgers A. The costs of treating hypertension in Australia: an economic analysis. Med J Aust. 2024 (in press).

5. The Department of Health and Aged Care of the Australian Government. 60-day prescriptions of PBS medicines. https://www.health.gov.au/our-work/60-day-prescriptions. Accessed 4 Sept 2023.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3